An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

The clinical burden of carbapenem-resistant Acinetobacter baumannii has worsened across U.S. hospitals in recent years, according to a study published April 17 in BMC Infectious Diseases.  The ...

In the microscopic battlefield of plant-microbe interactions, plants are constantly fighting off invading bacteria. New research reveals just how clever these bacterial invaders can be.

Typhoid fever might be rare in developed countries, but this ancient threat, thought to have been around for millennia, is ...

The following is a summary of “WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, ...

A new study shows that the simple application of computerized provider order entry prompts can reduce the use of unnecessary extended-spectrum antibiotics.

Experts say this new study highlights a more than tenfold increase in AMR-related infections in children in just three years.